Skip to content
10-Q

Quarterly Report

MEDICINOVA, INC. MNOV

0000950170-25-070461

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 49.05M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $36.57M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $40.36M
Current Liabilities Q1 2025 · Mar 31, 2025 $2.13M
Current Liabilities Q1 2025 · Dec 31, 2024 $2.96M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.5M
Total Liabilities Q1 2025 · Dec 31, 2024 $3.37M
Current Assets Q1 2025 · Mar 31, 2025 $37.68M
Current Assets Q1 2025 · Dec 31, 2024 $41.07M
Total Assets Q1 2025 · Mar 31, 2025 $52.43M
Total Assets Q1 2025 · Dec 31, 2024 $55.88M
Shares Diluted Q1 2025 · Mar 31, 2024 49.05M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$3.87M
Stockholders Equity Q1 2025 · Mar 31, 2024 $59.83M
Stockholders Equity Q1 2025 · Dec 31, 2023 $62.38M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.06
Eps Basic Q1 2025 · Mar 31, 2024 −$0.06
Sga Expense Q1 2025 · Mar 31, 2024 $1.35M
Rd Expense Q1 2025 · Mar 31, 2024 $1.7M
Net Income Q1 2025 · Mar 31, 2024 −$2.75M
Operating Income Q1 2025 · Mar 31, 2024 −$3.14M